Table 2. Antimicrobial susceptibility pattern of overall microorganisms.
| Antimicrobials | No. of isolates tested (%) | No. of sensitive isolates (%) | No. of intermediate isolates (%) | No. of resistant isolates (%) |
|---|---|---|---|---|
| Amikacin | 288 (100%) | 207 (71.87) | - | 81 (28.12) |
| Ampicillin | 409 (100%) | 61 (14.91) | 4 (0.97) | 344 (84.1) |
| AMC | 224 (100%) | 16 (7.15) | - | 208 (92.85) |
| Carbenicillin | 92 (100%) | 64 (69.56) | 2 (2.17) | 26 (28.26) |
| Cefazolin | 331 (100%) | 52 (15.7) | 6 (1.81) | 273 (82.47) |
| Cefepime | 173 (100%) | 27 (15.6%) | - | 146 (84.39) |
| Cephotaxime | 346 (100%) | 158 (45.66) | 10 (2.89) | 178 (51.44) |
| Ceftriaxone | 219 (100%) | 124 (56.62) | 1 (0.45) | 94 (42.92) |
| Ceftazidime | 105 (100%) | 68 (64.76) | 1 (0.95) | 36 (34.28) |
| Ciprofloxacin | 573 (100%) | 371 (64.74) | 5 (0.87) | 197 (34.38) |
| Cotrimoxazole | 394 (100%) | 202 (51.26) | - | 192 (48.73) |
| Eryhromycin | 100 (100%) | 62 (62) | 2 (2) | 36 (36) |
| Gentamycin | 596 (100%) | 423 (70.97) | 11 (1.84) | 162 (27.18) |
| Imipenum | 83 (100%) | 70 (84.33) | 2 (2.4) | 11 (13.25) |
| Meropenum | 153 (100%) | 100 (65.35) | 3 (1.96) | 50 (32.67) |
| Ofloxacin | 236 (100%) | 93 (39.4) | 1 (0.42) | 142 (60.16) |
| Tobramycin | 110 (100%) | 93 (84.54) | 1 (0.9) | 16 (14.54) |
| Piparacillin | 88 (100%) | 49 (55.68) | 1 (1.13) | 38 (43.18) |
| Vancomycin | 65 (100%) | 65 (100) | - | - |